BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

533 related articles for article (PubMed ID: 30419153)

  • 1. Heterogeneity of treatment dropout: PTSD, depression, and alcohol use disorder reductions in PTSD and AUD/SUD treatment noncompleters.
    Szafranski DD; Gros DF; Acierno R; Brady KT; Killeen TK; Back SE
    Clin Psychol Psychother; 2019 Mar; 26(2):218-226. PubMed ID: 30419153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated, exposure-based treatment for PTSD and comorbid substance use disorders: Predictors of treatment dropout.
    Szafranski DD; Snead A; Allan NP; Gros DF; Killeen T; Flanagan J; Pericot-Valverde I; Back SE
    Addict Behav; 2017 Oct; 73():30-35. PubMed ID: 28460246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive processing therapy for veterans with comorbid PTSD and alcohol use disorders.
    Kaysen D; Schumm J; Pedersen ER; Seim RW; Bedard-Gilligan M; Chard K
    Addict Behav; 2014 Feb; 39(2):420-7. PubMed ID: 24035644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High rates of PTSD treatment dropout: A possible red herring?
    Szafranski DD; Smith BN; Gros DF; Resick PA
    J Anxiety Disord; 2017 Apr; 47():91-98. PubMed ID: 28117192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of dropout in concurrent treatment of posttraumatic stress disorder and alcohol dependence: Rate of improvement matters.
    Zandberg LJ; Rosenfield D; Alpert E; McLean CP; Foa EB
    Behav Res Ther; 2016 May; 80():1-9. PubMed ID: 26972745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Integrated Exposure Therapy vs Integrated Coping Skills Therapy for Comorbid Posttraumatic Stress Disorder and Alcohol Use Disorder: A Randomized Clinical Trial.
    Norman SB; Trim R; Haller M; Davis BC; Myers US; Colvonen PJ; Blanes E; Lyons R; Siegel EY; Angkaw AC; Norman GJ; Mayes T
    JAMA Psychiatry; 2019 Aug; 76(8):791-799. PubMed ID: 31017639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized controlled trial of cognitive behaviour therapy for comorbid post-traumatic stress disorder and alcohol use disorders.
    Sannibale C; Teesson M; Creamer M; Sitharthan T; Bryant RA; Sutherland K; Taylor K; Bostock-Matusko D; Visser A; Peek-O'Leary M
    Addiction; 2013 Aug; 108(8):1397-1410. PubMed ID: 25328957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-treatment predictors of dropout from prolonged exposure therapy in patients with chronic posttraumatic stress disorder and comorbid substance use disorders.
    Belleau EL; Chin EG; Wanklyn SG; Zambrano-Vazquez L; Schumacher JA; Coffey SF
    Behav Res Ther; 2017 Apr; 91():43-50. PubMed ID: 28147254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Residual Symptoms of Posttraumatic Stress Disorder and Alcohol Use Disorder Following Integrated Exposure Treatment Versus Coping Skills Treatment.
    Tripp JC; Angkaw A; Schnurr PP; Trim RS; Haller M; Davis BC; Norman SB
    J Trauma Stress; 2020 Aug; 33(4):477-487. PubMed ID: 32557843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Examining sleep over time in a randomized control trial comparing two integrated PTSD and alcohol use disorder treatments.
    Colvonen PJ; Straus LD; Drummond SPA; Angkaw AC; Norman SB
    Drug Alcohol Depend; 2020 Apr; 209():107905. PubMed ID: 32065939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence-based psychotherapy completion and symptom improvement among returning combat veterans with PTSD.
    Myers US; Haller M; Angkaw AC; Harik JM; Norman SB
    Psychol Trauma; 2019 Feb; 11(2):216-223. PubMed ID: 30035552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Brief Exposure-Based Treatment vs Cognitive Processing Therapy for Posttraumatic Stress Disorder: A Randomized Noninferiority Clinical Trial.
    Sloan DM; Marx BP; Lee DJ; Resick PA
    JAMA Psychiatry; 2018 Mar; 75(3):233-239. PubMed ID: 29344631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Within-treatment clinical markers of dropout risk in integrated treatments for comorbid PTSD and alcohol use disorder.
    Kline AC; Panza KE; Harlé KM; Angkaw AC; Trim RS; Back SE; Norman SB
    Drug Alcohol Depend; 2021 Apr; 221():108592. PubMed ID: 33618193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in protective factors among U.S. Veterans with posttraumatic stress disorder, alcohol use disorder, and their comorbidity: Results from the National Health and Resilience in Veterans Study.
    Straus E; Norman SB; Haller M; Southwick SM; Hamblen JL; Pietrzak RH
    Drug Alcohol Depend; 2019 Jan; 194():6-12. PubMed ID: 30390551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of dropout from a randomized clinical trial of cognitive processing therapy for female veterans with military sexual trauma-related PTSD.
    Holder N; Holliday R; Wiblin J; LePage JP; Surís A
    Psychiatry Res; 2019 Jun; 276():87-93. PubMed ID: 31030005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Examining the association between psychiatric illness and suicidal ideation in a sample of treatment-seeking Canadian peacekeeping and combat veterans with posttraumatic stress disorder PTSD.
    Richardson JD; St Cyr KC; McIntyre-Smith AM; Haslam D; Elhai JD; Sareen J
    Can J Psychiatry; 2012 Aug; 57(8):496-504. PubMed ID: 22854032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substance use disorders and PTSD: Examining substance use, PTSD symptoms, and dropout following imaginal exposure.
    Jarnecke AM; Allan NP; Badour CL; Flanagan JC; Killeen TK; Back SE
    Addict Behav; 2019 Mar; 90():35-39. PubMed ID: 30355535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adults with Comorbid Posttraumatic Stress Disorder, Alcohol Use Disorder, and Opioid Use Disorder: The Effectiveness of Modified Prolonged Exposure.
    Peck KR; Schumacher JA; Stasiewicz PR; Coffey SF
    J Trauma Stress; 2018 Jun; 31(3):373-382. PubMed ID: 29786898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adoption by VA Residential Programs of Two Evidence-Based Psychotherapies for PTSD: Effect on Patient Outcomes.
    Cook JM; Schnurr PP; Simiola V; Thompson R; Hoff R; Harpaz-Rotem I
    Psychiatr Serv; 2019 Jul; 70(7):553-560. PubMed ID: 30966944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting treatment dropout among veterans receiving prolonged exposure therapy.
    Eftekhari A; Crowley JJ; Mackintosh MA; Rosen CS
    Psychol Trauma; 2020 May; 12(4):405-412. PubMed ID: 31318247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.